Potential surrogate endpoints for overall survival (OS) in immunotherapy (IO)-treated metastatic renal cell carcinoma (mRCC): An International Metastatic Database Consortium (IMDC) study

被引：0
|
作者：
Saliby, R. M. [1 ]
Xie, W. [2 ]
Wells, J. C. [3 ]
Saad, E. [1 ]
Eid, M. [1 ]
Semaan, K. [1 ]
Labaki, C. [4 ]
Ferrier, E. [5 ]
Zarba, M. [5 ]
Ebrahimi, H. [6 ]
Suarez Rodriguez, C. [7 ]
Ruiz, J. M. [8 ]
Powles, T. B. [9 ]
Wood, L. A. [10 ]
De Velasco Oria, G. A. [11 ]
Takemura, K. [12 ]
Braun, D. A. [13 ]
Heng, D. Y. C. [14 ]
Choueiri, T. K. [1 ]
机构：
[1] Dana Farber Canc Inst, Med Oncol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Dept Data Sci, Boston, MA 02115 USA
[3] BC Canc Agcy, Med Oncol, Vancouver, BC, Canada
[4] Dana Farber Canc Inst, Med Genet Unit, Boston, MA 02115 USA
[5] Tom Baker Canc Clin, Med Oncol, Calgary, AB, Canada
[6] City Hope Comprehens Canc Ctr, Med Oncol, Duarte, CA USA
[7] Vall dHebron Univ Hosp, Oncol Dept, Barcelona, Spain
[8] Ipsen Mexico S RL CV, Med Oncol, Mexico City, DF, Mexico
[9] Barts Hlth NHS Trust, St Bartholomews Hosp, Oncol Dept, London, England
[10] Dalhousie Univ, Div Med Oncol, Dept Med, Halifax, NS, Canada
[11] Hosp Univ 12 Octubre, Med Oncol Dept, Madrid, Spain
[12] JFCR, Canc Inst Hosp, Genitourinary Oncol, Koto Ku, Tokyo, Japan
[13] Yale Univ, Sch Med, Yale Canc Ctr, Ctr Mol & Cellular Oncol, New Haven, CT USA
[14] Tom Baker Canc Clin, Oncol Dept, Calgary, AB, Canada
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1797
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1704P
引用
收藏
页码：S1021 / S1022
页数：2
相关论文
共 50 条
  • [21] Real world outcomes of nivolumab and cabozantinib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Stukalin, Igor
    Wells, J. Connor
    Graham, Jeffrey
    Yuasa, Takeshi
    Beuselinck, Benoit
    Kollmannsberger, Christian K.
    Ernst, D. Scott
    Agarwal, Neeraj
    Le, Tri
    Donskov, Frede
    Hansen, Aaron Richard
    Bjarnason, Georg A.
    Srinivas, Sandy
    Wood, Lori
    Alva, Ajjai Shivaram
    Kanesvaran, Ravindran
    Fu, Simon Yuen Fai
    Davis, Ian D.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [22] Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC)-an International mRCC Database Consortium (IMDC) analysis
    Araujo, Daniel, V
    Wells, J. Connor
    Hansen, Aaron R.
    Dizman, Nazli
    Pal, Sumanta K.
    Beuselinck, Benoit
    Donskov, Frede
    Gan, Chun L.
    Yan, Flora
    Tran, Ben
    Kollmannsberger, Christian K.
    de Velasco, Guillermo
    Yuasa, Takeshi
    Reaume, M. Neil
    Ernst, D. Scott
    Powles, Thomas
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    Dudani, Shaan
    JOURNAL OF GERIATRIC ONCOLOGY, 2021, 12 (05) : 820 - 826
  • [23] Systemic treatments in favorable and very favorable risk metastatic renal cell carcinoma (mRCC): Real world evidence from the International mRCC Database Consortium (IMDC)
    Zarba, Martin
    Ferrier, Evan
    Wells, Connor
    El Zarif, Talal
    Basappa, Naveen S.
    Ebrahimi, Hedyeh
    Mckay, Rana R.
    Wood, Lori
    Beuselinck, Benoit
    Suarez, Cristina
    Takemura, Kosuke
    Lalani, Aly-Khan A.
    Li, Haoran
    Spain, Lavinia Anne
    Templeton, Arnoud J.
    Powles, Thomas
    Bjarnason, Georg A.
    de Velasco, Guillermo
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [24] Outcomes of first-line (1L) immuno-oncology (IO) combination therapies in metastatic renal cell carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC).
    Gan, Chun Loo
    Dudani, Shaan
    Wells, Connor J.
    Schmidt, Andrew Lachlan
    Bakouny, Ziad
    Szabados, Bernadett
    Parnis, Francis
    Wong, Shirley
    Lee, Jae-Lyun
    de Velasco, Guillermo
    Pal, Sumanta K.
    Davis, Ian D.
    Kanesvaran, Ravindran
    Wood, Lori
    Kollmannsberger, Christian K.
    McKay, Rana R.
    Beuselinck, Benoit
    Donskov, Frede
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [25] Association between treatment effects on disease progression (DP) endpoints and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
    Delea, T. E.
    Khuu, A.
    Kay, A.
    Zheng, J.
    Baladi, J. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [26] Fourth-Line Therapy in Metastatic Renal Cell Carcinoma (mRCC): Results from the International mRCC Database Consortium (IMDC) (vol 2, pg 31, 2018)
    Stukalin, Igor
    Wells, J. Connor
    Fraccon, Anna
    Pasini, Felice
    Porta, Camillo
    Lalani, Aly-Khan A.
    Srinivas, Sandy
    Bowman, I. Alex
    Brugarolas, James
    Lee, Jae-Lyun
    Donskov, Frede
    Beuselinck, Benoit
    Bamias, Aristotelis
    Rini, Brian I.
    Sim, Hao-Wen
    Agarwal, Neeraj
    Rha, Sun-Young
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    Heng, Daniel Y. C.
    KIDNEY CANCER, 2020, 4 (02) : 119 - 119
  • [27] Checkpoint inhibitors in metastatic renal cell carcinoma patients including elderly subgroups: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Yip, Steven
    Wells, Connor
    Moreira, Raphael Brandao
    Wong, Alex
    Srinivas, Sandy
    Beuselinck, Benoit
    Porta, Camillo
    Sim, Hao-Wen
    Ernst, D. Scott
    Rini, Brian I.
    Yuasa, Takeshi
    Basappa, Naveen S.
    Kanesvaran, Ravindran
    Wood, Lori
    Canil, Christina M.
    Kapoor, Anil
    Fu, Simon Yuen Fai
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC): An international mRCC database consortium (IMDC) analysis.
    Araujo, Daniel Vilarim
    Wells, Connor
    Hansen, Aaron Richard
    Dizman, Nazli
    Pal, Sumanta K.
    Beuselinck, Benoit
    Donskov, Frede
    Gan, Chun Loo
    Yan, Flora
    Tran, Ben
    Kollmannsberger, Christian K.
    de Velasco, Guillermo
    Yuasa, Takeshi
    Reaume, M. Neil
    Ernst, D. Scott
    Powles, Thomas
    Bjarnason, Georg A.
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    Dudani, Shaan
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Treatment-free survival after first-line therapies for metastatic renal cell carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) analysis.
    Gupta, Mehul
    Wells, Connor
    Regan, Meredith M.
    Xie, Wanling
    Navani, Vishal
    Saliby, Renee Maria
    Basappa, Naveen S.
    Donskov, Frede
    Yuasa, Takeshi
    Takemura, Kosuke null
    Kollmannsberger, Christian K.
    Crumbaker, Megan
    Lalani, Aly-Khan A.
    Powles, Thomas
    Pal, Sumanta Kumar
    Mckay, Rana R.
    Lee, Jae-Lyun
    Kanesvaran, Ravindran
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 390 - 390
  • [30] First-line therapy for metastatic renal cell carcinoma with pancreatic metastases: Results from the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC).
    Roussel, Eduard
    Kinget, Lisa
    Beuselinck, Benoit
    Albersen, Maarten
    Wells, Connor
    Ernst, Matthew Scott
    Donskov, Frede
    Schmidt, Andrew Lachlan
    Szabados, Bernadett
    Pal, Sumanta K.
    Meza, Luis A.
    Agarwal, Neeraj
    Weickhardt, Andrew James
    Davis, Ian D.
    Alva, Ajjai Shivaram
    Wood, Lori
    Porta, Camillo
    Choueiri, Toni K.
    Heng, Daniel Yick Chin
    Navani, Vishal
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
12345